ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR/ARHP Annual Meeting 2017

Abstract Number: 2411

In-Hospital Risk of Asthma in Patients with Rheumatoid Arthritis: A Cross-Sectional Nationwide Analysis

Yiming Luo1, Jiehui Xu2, Yumeng Wen1, Alvaro Ramos-Rodriguez3, Changchuan Jiang1, Shuyang Fang1, Mustafa Kagalwalla1 and Neha Ohri4, 1Department of Medicine, Mount Sinai St Luke's and Mount Sinai West Hospitals, Icahn School of Medicine at Mount Sinai, New York, NY, 2Department of Biostatistics, Mailman School of Public Health, Columbia University Medical Center, New York, NY, 3Mount Sinai St Luke's and Mount Sinai West Hospitals, Icahn School of Medicine at Mount Sinai, New York, NY, 4Division of Rheumatology, Department of Medicine, Mount Sinai St Luke's and Mount Sinai West Hospitals, Icahn School of Medicine at Mount Sinai, New York, NY

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR/ARHP Annual Meeting 2017

Date of first publication: September 18, 2017

Keywords: Asthma and rheumatoid arthritis (RA)

Session Information

Date: Tuesday, November 7, 2017

Title: Rheumatoid Arthritis – Clinical Aspects Poster III: Comorbidities

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:

Rheumatoid arthritis (RA) and asthma are both chronic inflammatory disorders. Lung pathology is a well-known extra-articular manifestation of RA and previous studies have shown an increased risk of asthma in patients with RA. Few studies have addressed the effects of RA on asthma exacerbations. We sought to explore the association of different asthma subtypes and asthma exacerbations in hospitalized adult patients with RA.

Methods:

We conducted a cross-sectional study using data from National Inpatient Sample (NIS) for the year of 2014. Diagnosis for asthma, subtypes of asthma (i.e. allergic asthma, non-allergic asthma, exercise-induced bronchospasm and cough variant asthma) and rheumatoid arthritis were identified using International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes. STATA software package was used for statistical analyses. Multivariate logistic regression models were created to adjust for potential confounders such as age, gender, race, insurance type, current tobacco abuse and obesity. Patients younger than 18 years old were excluded from the study. For asthma exacerbations, we also studied exacerbations related to acute respiratory infections (ARI) and status asthmaticus.

Results:

A total of 102,805 hospitalizations with a diagnosis of RA and 2,331,616 hospitalizations with a diagnosis of asthma were included in our study. Compared those without RA, asthma patients with RA are more likely to be older (mean age 63.1 vs 55.0), more female (85.8% vs 69.6%), more Caucasian and less African American (68.4% and 17.8% vs 62.8% and 21.6%). The adjusted OR for all types of asthma and RA was 1.52 (95% CI 1.49 – 1.56, p < 0.001). For asthma subtypes, the adjusted OR was statistically significant only for allergic asthma (OR 1.43, 95% CI 1.23 – 1.66, p < 0.001). There was no difference for non-allergic asthma (OR 1.42, 95% CI 0.84 – 2.42, p=0.190), exercise-induced bronchospasm (OR 0.91, 95% CI 0.51 – 1.60, p = 0.732), and cough-variant asthma (OR 0.89, 95% CI 0.43 – 1.86, p=0.766) in hospitalized patients with RA. For asthma exacerbations, RA was associated with a higher risk of overall exacerbations (OR 1.26, 95% CI 1.21 – 1.33 p < 0.001), including both ARI-related exacerbations (OR 1.36, 95% CI 1.17 – 1.57, p < 0.001) and non-ARI related exacerbations (OR 1.21 95% CI 1.11 – 1.31, p < 0.001). There was no difference for status asthmaticus (OR 1.17, 95% CI 0.92 – 1.48, p=0.191) in patients with RA.

Conclusion:

Our study is consistent with previous studies that RA is associated with a higher risk of asthma in hospitalized adult population. However, our subgroup analysis showed that RA is only associated with allergic subtype of asthma, which may imply complex cross-link between Th1 and Th2 type autoimmunity. Furthermore, RA is associated with higher risk of both ARI and non-ARI related asthma exacerbations, despite that RA patients are more likely to take oral steroid, which is also a Global Initiative for Asthma (GINA) guideline recommended Step 5 asthma control medication. It suggests that increased infection risk secondary to immunosuppressive medications and systemic inflammation due to RA may both play a role in the pathophysiology of asthma exacerbation.


Disclosure: Y. Luo, None; J. Xu, None; Y. Wen, None; A. Ramos-Rodriguez, None; C. Jiang, None; S. Fang, None; M. Kagalwalla, None; N. Ohri, None.

To cite this abstract in AMA style:

Luo Y, Xu J, Wen Y, Ramos-Rodriguez A, Jiang C, Fang S, Kagalwalla M, Ohri N. In-Hospital Risk of Asthma in Patients with Rheumatoid Arthritis: A Cross-Sectional Nationwide Analysis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/in-hospital-risk-of-asthma-in-patients-with-rheumatoid-arthritis-a-cross-sectional-nationwide-analysis/. Accessed .

ACR Meeting Abstracts - https://acrabstracts.org/abstract/in-hospital-risk-of-asthma-in-patients-with-rheumatoid-arthritis-a-cross-sectional-nationwide-analysis/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology